Roche will publish its Half Year Results of 2020 prior to the opening of the Swiss Stock Exchange on Thursday, 23rd July 2020 .
07:00 CEST / 06:00 BST / 01:00 AM EDT / 10:00 PM PDT (evening before)
Release will be e-mailed and posted on the Roche IR website click here
Presentation slides will be posted on the Roche IR website click here
We would like to invite all interested parties to watch the live video webcast.
13:00 - 14:30 CEST / 12:00 - 13:30 BST
07:00 - 08:30 AM EDT / 04:00 - 05:30 AM PDT
Live video webcast and conference call will start with presentations by senior management followed by a Q&A session (live access to the speakers).
Access to live audio webcast on 23 July 2020 (no pre-registration required)
Please access by clicking on ir.roche.com.
Access to Conference Call (pre-registration is only required in case you want to participate via phone and not via live video webcast)
You will receive phone numbers, passcode and your personal PIN to direct access the conference call by pre-registering here.
A replay of the live video webcast will be available following the event on the Roche Investor Relations website.
Best regards,
Karl Mahler
Head of Investor Relations and Roche Group Planning
Roche Investor Relations | |
Dr. Karl Mahler Phone: +41 61 68-78503 e-mail: karl.mahler@roche.com |
Jon Kaspar Bayard Phone: +41 61 68-83894 e-mail: jon_kaspar.bayard@roche.com |
Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com |
Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com |
Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com |
Dr. Gerard Tobin Phone: +41 61 68-72942 e-mail: gerard.tobin@roche.com |
Investor Relations North America | |
Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com |
Dr. Lisa Tuomi Phone: +1 650 467 8737 e-mail: tuomi.lisa@gene.com |
get the latest news and updates to your inbox.